Michael Gelband’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.53M Buy
359,884
+323,916
+901% +$3.58M 0.03% 530
2026
Q1
$334K Sell
35,968
-460,737
-93% -$4.46M ﹤0.01% 1292
2025
Q4
$5.02M Buy
496,705
+117,122
+31% +$1.16M 0.04% 468
2025
Q3
$4.08M Buy
+379,583
New +$4.24M 0.04% 487
2025
Q2
Sell
-699,352
Closed -$8.9M 1566
2025
Q1
$8.9M Buy
699,352
+647,655
+1,253% +$9.19M 0.09% 238
2024
Q4
$622K Buy
51,697
+12,604
+32% +$133K ﹤0.01% 1093
2024
Q3
$353K Buy
+39,093
New +$339K ﹤0.01% 1308

Other funds holding DCTH

Michael Gelband's DCTH Position: Q2 2026 in Review

Michael Gelband increased its Delcath Systems (DCTH) stake by 901% in Q2 2026, buying an estimated $3.58M and bringing the position to 359,884 shares worth $4.53M. The position accounts for 0.03% of the portfolio, ranked #530.

Michael Gelband first reported a position in DCTH in Q3 2024 and has held it in 7 quarters since. The position peaked at $8.9M in Q1 2025. 119 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

  • Michael Gelband held 359,884 shares of Delcath Systems worth $4.53M as of Q2 2026.
  • Michael Gelband bought 323,916 Delcath Systems shares in Q2 2026, an estimated $3.58M.
  • Delcath Systems made up 0.03% of Michael Gelband's portfolio in Q2 2026, its #530 holding.
  • Michael Gelband first reported a position in Delcath Systems in Q3 2024 and has held it in 7 quarters since.
  • Michael Gelband's Delcath Systems position peaked at $8.9M in Q1 2025.
  • 119 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.